Read + Share
Hong DS, Moore KN, Bendell JC, Karp DD, et al. Preclinical Evaluation and Phase Ib Study of Prexasertib, a CHK1 Inhibitor, and
Samotolisib (LY3023414), a Dual PI3K/mTOR Inhibitor. Clin Cancer Res 2021;27:1864-1874.
PMID: 33495309
|
 |
|
Hong DS, Moore KN, Bendell JC, Karp DD, et al. Preclinical Evaluation and Phase Ib Study of Prexasertib, a CHK1 Inhibitor, and
Samotolisib (LY3023414), a Dual PI3K/mTOR Inhibitor. Clin Cancer Res 2021;27:1864-1874.
PMID: 33495309
|
|
|
|